NCT03468478View on ClinicalTrials.gov

Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

1,209

Participants

Timeline

Start Date

June 18, 2017

Primary Completion Date

March 18, 2021

Study Completion Date

August 23, 2021

Conditions
Kidney Transplant Infection
Interventions
DRUG

Sirolimus

sirolimus combined to reduced dose of tacrolimus

DRUG

Everolimus

everolimus combined to reduced dose of tacrolimus

DRUG

Mycophenolic acid

Control arm: mycophenolate combined to regular tacrolimus

Trial Locations (1)

04038002

Hospital do Rim, São Paulo

All Listed Sponsors
lead

Hospital do Rim e Hipertensão

OTHER

NCT03468478 - Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation | Biotech Hunter | Biotech Hunter